These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

333 related items for PubMed ID: 15746161

  • 1. Bowman-Birk inhibitor abates proteasome function and suppresses the proliferation of MCF7 breast cancer cells through accumulation of MAP kinase phosphatase-1.
    Chen YW, Huang SC, Lin-Shiau SY, Lin JK.
    Carcinogenesis; 2005 Jul; 26(7):1296-306. PubMed ID: 15746161
    [Abstract] [Full Text] [Related]

  • 2. The antiproliferative effect of sildenafil on pulmonary artery smooth muscle cells is mediated via upregulation of mitogen-activated protein kinase phosphatase-1 and degradation of extracellular signal-regulated kinase 1/2 phosphorylation.
    Li B, Yang L, Shen J, Wang C, Jiang Z.
    Anesth Analg; 2007 Oct; 105(4):1034-41, table of contents. PubMed ID: 17898384
    [Abstract] [Full Text] [Related]

  • 3. Evidence that mitogen-activated protein kinase phosphatase-1 induction by proteasome inhibitors plays an antiapoptotic role.
    Small GW, Shi YY, Edmund NA, Somasundaram S, Moore DT, Orlowski RZ.
    Mol Pharmacol; 2004 Dec; 66(6):1478-90. PubMed ID: 15448190
    [Abstract] [Full Text] [Related]

  • 4. Protein kinase Cdelta-mediated proteasomal degradation of MAP kinase phosphatase-1 contributes to glutamate-induced neuronal cell death.
    Choi BH, Hur EM, Lee JH, Jun DJ, Kim KT.
    J Cell Sci; 2006 Apr 01; 119(Pt 7):1329-40. PubMed ID: 16537649
    [Abstract] [Full Text] [Related]

  • 5. Proteasome inhibitors induce a p38 mitogen-activated protein kinase (MAPK)-dependent anti-apoptotic program involving MAPK phosphatase-1 and Akt in models of breast cancer.
    Shi YY, Small GW, Orlowski RZ.
    Breast Cancer Res Treat; 2006 Nov 01; 100(1):33-47. PubMed ID: 16807678
    [Abstract] [Full Text] [Related]

  • 6. Effects of the Bowman-Birk inhibitor on clonogenic survival and cisplatin- or radiation-induced cytotoxicity in human breast, cervical, and head and neck cancer cells.
    Zhang L, Wan XS, Donahue JJ, Ware JH, Kennedy AR.
    Nutr Cancer; 1999 Nov 01; 33(2):165-73. PubMed ID: 10368812
    [Abstract] [Full Text] [Related]

  • 7. Negative growth control of osteosarcoma cell by Bowman-Birk protease inhibitor from soybean; involvement of connexin 43.
    Saito T, Sato H, Virgona N, Hagiwara H, Kashiwagi K, Suzuki K, Asano R, Yano T.
    Cancer Lett; 2007 Aug 18; 253(2):249-57. PubMed ID: 17343982
    [Abstract] [Full Text] [Related]

  • 8. Mitogen-activated protein kinase phosphatase-1 is a mediator of breast cancer chemoresistance.
    Small GW, Shi YY, Higgins LS, Orlowski RZ.
    Cancer Res; 2007 May 01; 67(9):4459-66. PubMed ID: 17483361
    [Abstract] [Full Text] [Related]

  • 9. Dipyridamole activation of mitogen-activated protein kinase phosphatase-1 mediates inhibition of lipopolysaccharide-induced cyclooxygenase-2 expression in RAW 264.7 cells.
    Chen TH, Kao YC, Chen BC, Chen CH, Chan P, Lee HM.
    Eur J Pharmacol; 2006 Jul 17; 541(3):138-46. PubMed ID: 16765938
    [Abstract] [Full Text] [Related]

  • 10. MKP-1-induced dephosphorylation of extracellular signal-regulated kinase is essential for triggering nitric oxide-induced apoptosis in human breast cancer cell lines: implications in breast cancer.
    Pervin S, Singh R, Freije WA, Chaudhuri G.
    Cancer Res; 2003 Dec 15; 63(24):8853-60. PubMed ID: 14695202
    [Abstract] [Full Text] [Related]

  • 11. Effect of the Bowman-Birk inhibitor (a soy protein) on in vitro bladder neck/urethral and penile corporal smooth muscle activity.
    Malkowicz SB, Liu SP, Broderick GA, Wein AJ, Kennedy AR, Levin RM.
    Neurourol Urodyn; 2003 Dec 15; 22(1):54-7. PubMed ID: 12478602
    [Abstract] [Full Text] [Related]

  • 12. Bowman-Birk inhibitor suppresses production of superoxide anion radicals in differentiated HL-60 cells.
    Ware JH, Wan XS, Kennedy AR.
    Nutr Cancer; 1999 Dec 15; 33(2):174-7. PubMed ID: 10368813
    [Abstract] [Full Text] [Related]

  • 13. MKP-1 contributes to oxidative stress-induced apoptosis via inactivation of ERK1/2 in SH-SY5Y cells.
    Kim GS, Choi YK, Song SS, Kim WK, Han BH.
    Biochem Biophys Res Commun; 2005 Dec 30; 338(4):1732-8. PubMed ID: 16289033
    [Abstract] [Full Text] [Related]

  • 14. Bowman-Birk protease inhibitor activates DNA-dependent protein kinase and reduces formation of radiation-induced dicentric chromosomes.
    Dittmann K, Virsik-Köpp P, Mayer C, Rave-Fränk M, Rodemann HP.
    Int J Radiat Biol; 2003 Oct 30; 79(10):801-8. PubMed ID: 14630539
    [Abstract] [Full Text] [Related]

  • 15. Activation of ERK1/2 MAP kinases in familial amyloidotic polyneuropathy.
    Monteiro FA, Sousa MM, Cardoso I, do Amaral JB, Guimarães A, Saraiva MJ.
    J Neurochem; 2006 Apr 30; 97(1):151-61. PubMed ID: 16515552
    [Abstract] [Full Text] [Related]

  • 16. Proteases occurring in the cell membrane: a possible cell receptor for the Bowman-Birk type of protease inhibitors.
    Yavelow J, Caggana M, Beck KA.
    Cancer Res; 1987 Mar 15; 47(6):1598-601. PubMed ID: 3545448
    [Abstract] [Full Text] [Related]

  • 17. [A study on the regulatory mechanisms of mitogen-activated protein kinase phosphatase-1 in hypoxia inducible factor-1 trans-activation].
    Qiao TD, Liu CJ, Shi YQ, DU YL, Han S, Fan DM.
    Zhonghua Yi Xue Za Zhi; 2005 Mar 02; 85(8):555-9. PubMed ID: 15949338
    [Abstract] [Full Text] [Related]

  • 18. Soybean Bowman-Birk protease inhibitor is a highly effective inhibitor of human mast cell chymase.
    Ware JH, Wan XS, Rubin H, Schechter NM, Kennedy AR.
    Arch Biochem Biophys; 1997 Aug 01; 344(1):133-8. PubMed ID: 9244390
    [Abstract] [Full Text] [Related]

  • 19. The role of mitogen-activated protein kinase phosphatase-1 in oxidative damage-induced cell death.
    Zhou JY, Liu Y, Wu GS.
    Cancer Res; 2006 May 01; 66(9):4888-94. PubMed ID: 16651445
    [Abstract] [Full Text] [Related]

  • 20. Leptin-induced growth of human ZR-75-1 breast cancer cells is associated with up-regulation of cyclin D1 and c-Myc and down-regulation of tumor suppressor p53 and p21WAF1/CIP1.
    Chen C, Chang YC, Liu CL, Chang KJ, Guo IC.
    Breast Cancer Res Treat; 2006 Jul 01; 98(2):121-32. PubMed ID: 16752079
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.